camptothecin has been researched along with glycyrrhizic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, Y; Ge, Y; Meng, L; Yu, X; Zhang, Y; Zhao, X; Zu, Y | 1 |
| Cai, J; Deng, Y; Huang, H; Li, G; Luo, S; Lv, X; Zhang, Q; Zhao, B | 1 |
| Dushkin, AV; Feng, Z; Lu, Z; Su, C; Su, W; Wang, H; Yu, J; Zhang, Q | 1 |
3 other study(ies) available for camptothecin and glycyrrhizic acid
| Article | Year |
|---|---|
Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Hepatocellular; Cattle; Cell Line, Tumor; Drug Carriers; Glycyrrhizic Acid; Hemolysis; Humans; Liver Neoplasms; Nanoparticles; Particle Size; Rabbits; Serum Albumin, Bovine | 2013 |
Formulation of injectable glycyrrhizic acid-hydroxycamptothecin micelles as new generation of DNA topoisomerase I inhibitor for enhanced antitumor activity.
Topics: Administration, Intravenous; Animals; Camptothecin; Cell Proliferation; Drug Carriers; Drug Stability; Glycyrrhizic Acid; Hep G2 Cells; Humans; Male; Mice; Micelles; Neoplasms; Particle Size; Solubility; Topoisomerase I Inhibitors; Toxicity Tests; Xenograft Model Antitumor Assays | 2019 |
Preparation of camptothecin micelles self-assembled from disodium glycyrrhizin and tannic acid with enhanced antitumor activity.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Glycyrrhizic Acid; Hep G2 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Particle Size; Permeability; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Tannins | 2021 |